Skip to content
Screener

Medtronic MDT Cardiovascular — Selling, general, and administrative expense

Other segment segments

Neuroscience
$875M+7.6%
Medical Surgical
$650M+9.6%
Diabetes
$300M+12.8%

Similar metrics at other companies

Materion logo
MTRNOther — Selling, general, and administrative expense
$11.73M+59.5%
SKY
SKYTLegacy SkyWater — Selling, general, and administrative expense
$25.97M+72.8%
SKY
SKYTSkyWater Texas — Selling, general, and administrative expense
$6.47M
Materion logo
MTRNElectronic Materials — Selling, general, and administrative expense
$10.72M+17.5%
Materion logo
MTRNPerformance Materials — Selling, general, and administrative expense
$14.88M+4.5%
Materion logo
MTRNPrecision Optics — Selling, general, and administrative expense
$4.99M+15.6%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$110.07B-3.9%
Enterprise value$137.33B-3.2%
P/E22.9×-1.6×
P/S-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354
(in millions)CardiovascularNeuroscienceMedical SurgicalTotal
Less:
Cost of products sold, excluding amortization of intangible assets4,6953,1513,47611,323
Research and development expense1,1366166862,438
Selling, general, and administrative expense4,5193,4212,51110,451
Other segment items(3)(46)36144
Reportable segment operating profit$3,672$3,062$2,128$8,862
Reconciliation of segment profit / (loss)
Other operating segments profit(1)106

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's cardiovascular — selling, general, and administrative expense?
Medtronic (MDT) reported cardiovascular — selling, general, and administrative expense of $1.19B in Q1 2026.
How has Medtronic's cardiovascular — selling, general, and administrative expense changed year-over-year?
Medtronic's cardiovascular — selling, general, and administrative expense increased by 17.4% year-over-year, from $1.01B to $1.19B.
What is the long-term trend for Medtronic's cardiovascular — selling, general, and administrative expense?
Over 3 years (2023 to 2026), Medtronic's cardiovascular — selling, general, and administrative expense has grown at a 19.4% compound annual growth rate (CAGR), from $2.65B to $4.52B.
What does cardiovascular — selling, general, and administrative expense mean?
This includes all operating expenses for the cardiovascular segment related to sales, marketing, and general administrative support. It covers the costs of the sales force, medical education, and back-office functions required to support the segment's commercial activities. Managing this expense is critical for maintaining healthy operating margins.

Ask your AI about Medtronic's cardiovascular — selling, general, and administrative expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude